We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Molecular Markers of Aging Identified

By Biotechdaily staff writers
Posted on 16 Nov 2004
Investigators have made an important finding in the understanding of cellular aging. More...
New research demonstrates that as tissues and cells age, the expression of two proteins called p16INK4a and ARF drastically increases. This increase in expression, more than 100-fold in some tissues, suggests a strong link between cellular aging and upregulation, or increased production, of p16INK4a and ARF.

"At the very least, our work suggests that looking at the expression of one or both proteins will make a great biomarker of aging--a tool to clinically determine the actual molecular age of people, as opposed to just their chronological age. We all know people that we consider to be a young 65, and we believe they won't demonstrate as much p16INK4a or ARF expression as others of the same age,” said Dr. Normal Sharpless, the senior author of the study, from the University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center (UNC, NC, USA) and assistant professor of medicine and genetics at UNC's School of Medicine. The study was published in the November 1, 2204, issue of the Journal of Clinical Investigation.

In addition to finding molecular targets that may slow down aging in the future, the study may also provide clinical applications that can be used right now. Understanding the molecular age of a tissue may also help physicians pick the younger-appearing, most viable tissue and organs for transplantation, to predict how well a patient will heal after surgery, to be able to distinguish the regenerative capability of a patient's bone marrow, and predict future chemotherapy toxicity in a cancer patient.

Both ARF and p16INK4a are known powerful tumor suppressors. This study suggests that the significant anticancer function of these proteins to restrict cellular growth might in turn cause aging. "Proliferation of cells is important in the repair and regrowth of tissues. In fact, we grow old in part because our bodies' ability to regenerate tissues decreases as we age,” said Dr. Sharpless. "We believe an untoward effect of increased p16INK4a and ARF expression outside of cancer is a decrease in cellular proliferation needed to sustain this regeneration.”

The investigators also discovered that the increase of p16INK4a and ARF can be considerably inhibited by decreasing caloric intake, a known decelerator of aging. This effect suggests that decreased expression of p16INK4a and ARF could mediate this anti-aging result of caloric restriction.

"Our results suggest that going on a short-term diet will not reverse the aging process; only long-term restrictions appeared to have an effect on p16INK4a and ARF expression. Therefore, our results would be consistent with the idea that short-term caloric restriction prior to surgery would improve postoperative wound healing,” noted Dr. Sharpless.

This research has strong implications for stem cell regeneration, he added. Stem cells are self-replenishing cells than constantly differentiate and divide into the component cells that comprise the tissues in the human body.

"As tissue stem cells age, they appear to express more p16INK4a and ARF, which would stop those cells from replenishing. As people age, they could just run out of functioning stem cells,” said Dr. Sharpless.

Stem cell depletion could affect the body's capacity to heal after surgery or injury, and may also predict the ability of specific diseases, such as cardiomyopathy, to progress, according to Dr. Sharpless.


Related Links:
UNC Lineberger Comprehensive Cancer Center

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
hCG Whole Blood Pregnancy Test
VEDALAB hCG-CHECK-1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.